Dakota Brock
About Dakota Brock
Dakota Brock is a scientist at Procter & Gamble with a background in biochemistry and chemistry, specializing in cell biology and therapeutic peptides.
Current Position at Procter & Gamble
Dakota Brock is currently serving as a Scientist at Procter & Gamble in Mason, Ohio, United States. He has been with the company since 2022. In this role, Brock applies his expertise in biochemistry and cell biology to various research and development projects.
Previous Experience at Procter & Gamble
Before his current role, Dakota Brock worked as a Postdoctoral Research Fellow at Procter & Gamble from 2021 to 2022. During his tenure, he focused on advancing research methodologies and contributed to the company’s scientific explorations. His experience in this capacity helped prepare him for his current Scientist position.
Postdoctoral Research at Merck
Dakota Brock worked at Merck in Rahway, NJ, from 2019 to 2021 as a Postdoctoral Research Fellow. His research primarily centered on the physicochemical properties affecting intracellular exposure and metabolic susceptibility of therapeutic peptides. This role allowed Brock to deepen his understanding of therapeutic applications and experimental biology.
Educational Background in Chemistry and Biochemistry
Dakota Brock holds a Doctor of Philosophy (Ph.D.) in Biochemistry from Texas A&M University, where he studied from 2013 to 2019. His doctoral research included the use of cell-penetrating peptides to facilitate the delivery of cell-impermeable cargoes into live cells. Brock also earned a Bachelor of Arts (B.A.) in Chemistry from the same institution, which he completed from 2009 to 2013.
Research Contributions at Texas A&M University
During his extensive academic career at Texas A&M University, Dakota Brock held several roles including Undergraduate Research Assistant and Graduate Teaching Assistant. He worked on numerous research projects, such as investigating the interaction between guanidinium-rich CPPs and the negatively charged lipid BMP, and exploring pre-lysosomal protein degradation using dfTAT. His work significantly contributed to the understanding of cell biology and membrane translocation mechanisms.